<DOC>
	<DOCNO>NCT00157911</DOCNO>
	<brief_summary>Patients undergo 4-week placebo lead-in diet period , 12-week treatment period . Clinical efficacy safety evaluate week 4 , 8 12 . This study take approximately 18 week individual patient complete include post-visit week 14 .</brief_summary>
	<brief_title>A Study Evaluate Ezetimibe Korean Patients With Primary Hypercholesterolemia ( 0653-042 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Korean male female least 18 year age hypercholesterolemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>